Mandarin Capital Acquires Stakes In Italian Drug Firm Mipharm

Mandarin Capital Partners has acquired a majority stake in Mipharm Spa, an Italian contract manufacturing organization engaged in the manufacturing and packaging of a wide range of drugs, the Sino-Europe private equity firm said today.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets